These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36848992)

  • 1. Putative adverse outcome pathways of the male reproductive toxicity derived from toxicological studies of perfluoroalkyl acids.
    Lu T; Mortimer M; Li F; Li Z; Chen L; Li M; Guo LH
    Sci Total Environ; 2023 May; 873():162439. PubMed ID: 36848992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative adverse outcome pathways for silver nanoparticle toxicity on mammalian male reproductive system: a literature review.
    Kose O; Mantecca P; Costa A; Carrière M
    Part Fibre Toxicol; 2023 Jan; 20(1):1. PubMed ID: 36604752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-level overview of the OECD AOP Development Programme.
    Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
    Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
    Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
    Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis-based adverse outcome pathway for the male reproductive toxicity induced by microplastics and nanoplastics in mammals.
    Hu Y; Shen M; Wang C; Huang Q; Li R; Dorj G; Gombojav E; Du J; Ren L
    J Hazard Mater; 2024 Mar; 465():133375. PubMed ID: 38160553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, Validation, and Application of a Human Reproductive Toxicity Prediction Model Based on Adverse Outcome Pathway.
    Tan H; Wu J; Zhang R; Zhang C; Li W; Chen Q; Zhang X; Yu H; Shi W
    Environ Sci Technol; 2022 Sep; 56(17):12391-12403. PubMed ID: 35960020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AOP Report: Inhibition of Chitin Synthase 1 Leading to Increased Mortality in Arthropods.
    Schmid S; Song Y; Tollefsen KE
    Environ Toxicol Chem; 2021 Aug; 40(8):2112-2120. PubMed ID: 33818824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
    Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
    ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
    Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
    ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Mitochondrial Dysfunction to Organismal and Population Health in the Context of Environmental Pollutants: Progress and Considerations for Mitochondrial Adverse Outcome Pathways.
    Dreier DA; Mello DF; Meyer JN; Martyniuk CJ
    Environ Toxicol Chem; 2019 Aug; 38(8):1625-1634. PubMed ID: 31034624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semantic characterization of adverse outcome pathways.
    Wang RL
    Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the adverse outcome pathway framework to genotoxic modes of action.
    Sasaki JC; Allemang A; Bryce SM; Custer L; Dearfield KL; Dietz Y; Elhajouji A; Escobar PA; Fornace AJ; Froetschl R; Galloway S; Hemmann U; Hendriks G; Li HH; Luijten M; Ouedraogo G; Peel L; Pfuhler S; Roberts DJ; Thybaud V; van Benthem J; Yauk CL; Schuler M
    Environ Mol Mutagen; 2020 Jan; 61(1):114-134. PubMed ID: 31603995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse outcome pathways of PBDEs inducing male reproductive toxicity.
    Zhang Y; Xie J; Ouyang Y; Li S; Sun Y; Tan W; Ren L; Zhou X
    Environ Res; 2024 Jan; 240(Pt 1):117598. PubMed ID: 37939807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
    Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
    Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.
    Halappanavar S; van den Brule S; Nymark P; Gaté L; Seidel C; Valentino S; Zhernovkov V; Høgh Danielsen P; De Vizcaya A; Wolff H; Stöger T; Boyadziev A; Poulsen SS; Sørli JB; Vogel U
    Part Fibre Toxicol; 2020 May; 17(1):16. PubMed ID: 32450889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity.
    Vinken M
    Methods Mol Biol; 2016; 1425():325-37. PubMed ID: 27311472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence.
    Perkins EJ; Antczak P; Burgoon L; Falciani F; Garcia-Reyero N; Gutsell S; Hodges G; Kienzler A; Knapen D; McBride M; Willett C
    Toxicol Sci; 2015 Nov; 148(1):14-25. PubMed ID: 26500288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.
    Arnesdotter E; Gijbels E; Dos Santos Rodrigues B; Vilas-Boas V; Vinken M
    Methods Mol Biol; 2022; 2425():521-535. PubMed ID: 35188645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse outcome pathway from activation of the AhR to breast cancer-related death.
    Benoit L; Jornod F; Zgheib E; Tomkiewicz C; Koual M; Coustillet T; Barouki R; Audouze K; Vinken M; Coumoul X
    Environ Int; 2022 Jul; 165():107323. PubMed ID: 35660951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.